Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis.
about
Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitusMoving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug rewardImpact of postprandial glycaemia on health and prevention of diseaseSex differences in the physiology of eatingThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsLiraglutide and obesity: a review of the data so far.Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor AgonistsTolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.Glucagon-like peptide-1 reduces pancreatic β-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats.Exendin-4 Protects MIN6 Cells from t-BHP-Induced Apoptosis via IRE1-JNK-Caspase-3 SignalingThe gut sensor as regulator of body weight.Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunitiesGLP-1 secretion by microglial cells and decreased CNS expression in obesity.Peptide regulators of peripheral taste function.Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male miceMolecular neuroendocrine targets for obesity therapy.GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.Continuous parenteral and enteral nutrition induces metabolic dysfunction in neonatal pigsUpdate on incretin hormones.Incretin hormones and the satiation signal.The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?User's guide to mechanism of action and clinical use of GLP-1 receptor agonists.Hippocampus Contributions to Food Intake Control: Mnemonic, Neuroanatomical, and Endocrine Mechanisms.Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of PeptidesCentral glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus.GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.Detection of extracellular glucose by GLUT2 contributes to hypothalamic control of food intake.Glucagon-like peptide-1 in the rat brain: distribution of expression and functional implication.Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation.Mucosal glucagon-like peptide 1 (GLP-1) responses are mediated by calcitonin gene-related peptide (CGRP) in the mouse colon and both peptide responses are area-specific.
P2860
Q26774021-EAF0CC10-9F27-43B3-9DB7-B949146133FBQ26826926-1E0669D5-2137-4B1A-A783-F28F17734CD3Q26862823-09D80EEA-27EE-4774-A423-8B906FCC2923Q27007513-FB895507-189B-4880-865F-FB563A8B5EC8Q30486707-A955D5E6-A297-4DC3-B568-EE932E179898Q30924982-67FA190F-EB01-48B2-BE03-AE3A41E7A256Q33521451-4C7CCD51-C72F-4BE6-8D3B-61285D93C40DQ33570118-2C477C7B-2FD3-4D1D-A2D4-3C631FA82804Q33911780-E5737431-8344-472C-B031-B2D7A008E1D1Q34240080-E9D462E0-096B-421A-844F-4D785DCDC750Q35535513-D2C1EE5D-05B6-4914-8284-117D31925E2DQ35640531-D24F8A7A-F801-4AFE-8985-9B02436E72FEQ35834277-FC52759B-3236-4E6F-9D24-32949F61EC3FQ35893496-5AF0C58F-3F5D-4B5E-9AC7-FA110467A673Q36153247-77A44705-EE05-4EEB-A8A8-F1DC39F3F209Q36539234-F5D68DA8-BD05-4BE1-A170-AC32A7F3F593Q36728791-1D195738-9901-4BD6-B4E6-96C0DA6E302DQ37240144-5DBE0192-D7BA-42FD-AB20-2EC16378E3E7Q37569030-E7C4F803-1703-4120-9369-5727CB286EC3Q37629291-1F8AB160-EC61-4878-8040-DF2174745073Q37724046-75D02D7E-C46F-4680-9E5A-6231B2886550Q38006504-B129E780-EC11-4477-8A19-2A7237CD2A91Q38072203-A3E97601-78DE-4486-8324-663A908F4EC7Q38527885-D72C2C6D-8975-49BB-9AD4-A0AAC1C0C19DQ38587097-D29F9AF6-4BFF-4091-A96B-7A6FEDB4E305Q38629710-D89B754F-6CC0-45D7-A340-5F6580C07CEDQ39146023-776F3FE1-5DE5-410D-B918-0B81925C133CQ39206330-FE0A7449-31C6-4EE1-AEA3-C05AF6ECE3AEQ42578569-B9F91CD4-DDAF-4126-8DD6-B27B708EB999Q42582553-722A34AE-45DC-4988-B74B-C49CABFC9966Q43152530-D977B66F-87CB-486E-8F35-54DAEEACFDA5Q46278128-02ADD7E1-E236-42FD-BB45-81BF572F6C19Q47443146-D8A5B4A6-C569-4ADF-9815-FE2B82EE78C8Q47652208-43F408D1-9F6C-4F8C-93CD-927831BE38BDQ48147207-9FF6606F-0028-4E37-B53C-9CAE9C322917
P2860
Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minireview: finding the sweet ...... eding and glucose homeostasis.
@en
Minireview: finding the sweet ...... eding and glucose homeostasis.
@nl
type
label
Minireview: finding the sweet ...... eding and glucose homeostasis.
@en
Minireview: finding the sweet ...... eding and glucose homeostasis.
@nl
prefLabel
Minireview: finding the sweet ...... eding and glucose homeostasis.
@en
Minireview: finding the sweet ...... eding and glucose homeostasis.
@nl
P2860
P356
P1433
P1476
Minireview: finding the sweet ...... eeding and glucose homeostasis
@en
P2093
Diana L Williams
P2860
P304
P356
10.1210/EN.2009-0220
P407
P577
2009-04-23T00:00:00Z